Stromal Cell-Derived Factor-1/CXCL12 Selectively Counteracts Inhibitory Effects of Myelosuppressive Chemokines on Hematopoietic Progenitor Cell Proliferation In Vitro
- 1 April 2005
- journal article
- research article
- Published by Mary Ann Liebert Inc in Stem Cells and Development
- Vol. 14 (2), 199-203
- https://doi.org/10.1089/scd.2005.14.199
Abstract
A variety of cytokines and chemokines exert potent myelosuppressive effects that play a role in the maintenance of hematopoiesis, which, if unchecked, may result in pathological impairment of blood cell production. Processes that modulate these myelosuppressive effects are not well defined. Here we demonstrate that stromal cell-derived factor-1 (SDF-1/CXCL12), known for its ability to attract and to promote survival of hematopoietic progenitor cells (HPCs) and stem cells, blocks the effects of a broad range of myelosuppressive chemokines on proliferation of HPCs in vitro. The regulatory effects of SDF/CXCL12 on colony formation by mouse bone marrow granulocyte-macrophage (CFUGM), erythroid (BFU-E), and multipotential (CFU-GEMM) progenitor cells were assessed. These cells were stimulated to proliferate by combinations of growth factors, such that responses of immature HPCs could be assessed. SDF-1/CXCL12 potently blocked myelosuppressive responses induced by CCL2/MCP-1, CCL3/MIP-1α, CCL19/CKβ-11, CCL25/TECK, CXCL4/PF4, CXCL8/IL-8, CXCL10/IP-10, and XCL1/Lymphotactin. However, SDF/CDL12 did not influence myelosuppression induced by tumor necrosis factor (TNF)-α, interferon (IFN)-γ, transforming growth factor (TGF)-β or the iron-binding proteins H-ferritin or lactoferrin (LF). LF, previously shown to suppress release of growth factors, is shown here to also suppress proliferation of immature subsets of HPCs. HPCs from marrows of mice expressing an SDF-1/CXCL12 transgene were insensitive to inhibition by SDF/CXCL12-sensitive myelosuppressive chemokines, but not to SDF/CCL12-insensitive cytokines (TNF-α, IFN-γ, TGF-β, H-Ferritin, or LF). Thus, SDF-1/CXCL12 differentially and selectively regulates suppression of HPC proliferation by chemokines. These effects may counter myelosuppressive effects of certain chemokines in vivo, where proliferation of HPCs must be sustained.Keywords
This publication has 22 references indexed in Scilit:
- Enhancement of Cell Survival by Stromal Cell-Derived Factor-1/CXCL12 Involves Activation of CREB and Induction of Mcl-1 and c-Fos in Factor-Dependent Human Cell Line MO7eStem Cells and Development, 2004
- Modulation of Hematopoietic Stem Cell Homing and Engraftment by CD26Science, 2004
- Stromal cell-derived factor-1/CXCL12 directly enhances survival/antiapoptosis of myeloid progenitor cells through CXCR4 and Gαi proteins and enhances engraftment of competitive, repopulating stem cellsJournal of Leukocyte Biology, 2003
- A Coordinated Change in Chemokine Responsiveness Guides Plasma Cell MovementsThe Journal of Experimental Medicine, 2001
- Chemokines, chemokine receptors and hematopoiesisImmunological Reviews, 2000
- Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar developmentNature, 1998
- Involvement of Interleukin (IL) 8 receptor in negative regulation of myeloid progenitor cells in vivo: evidence from mice lacking the murine IL-8 receptor homologue.The Journal of Experimental Medicine, 1996
- Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1Nature, 1996
- Human chemokines: enhancement of specific activity and effects in vitro on normal and leukemic progenitors and a factor-dependent cell line and in vivo in miceAnnals of Hematology, 1995
- Signal Sequence Trap: a Cloning Strategy for Secreted Proteins and Type I Membrane ProteinsScience, 1993